ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of MXN 6.03 billion. The enterprise value is 25.29 billion.

Market Cap	6.03B
Enterprise Value	25.29B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	141.55M
Shares Outstanding	n/a
Shares Change (YoY)	+60.61%
Shares Change (QoQ)	+3.26%
Owned by Insiders (%)	17.81%
Owned by Institutions (%)	15.62%
Float	93.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	441.59
PB Ratio	1.03
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.40

Financial Position

The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.01.

Current Ratio	10.32
Quick Ratio	9.39
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-34,177.80

Financial Efficiency

Return on equity (ROE) is -41.81% and return on invested capital (ROIC) is -27.65%.

Return on Equity (ROE)	-41.81%
Return on Assets (ROA)	-25.85%
Return on Invested Capital (ROIC)	-27.65%
Return on Capital Employed (ROCE)	-52.98%
Revenue Per Employee	66,895
Profits Per Employee	-6.39M
Employee Count	204
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid 67.88 million in taxes.

Income Tax	67.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.69%
50-Day Moving Average	50.84
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.03
Average Volume (20 Days)	24,747

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.02

Income Statement

In the last 12 months, ProKidney had revenue of MXN 13.65 million and -1.30 billion in losses. Loss per share was -9.97.

Revenue	13.65M
Gross Profit	13.65M
Operating Income	-3.13B
Pretax Income	-2.85B
Net Income	-1.30B
EBITDA	-3.02B
EBIT	-3.13B
Loss Per Share	-9.97

Full Income Statement

Balance Sheet

The company has 4.98 billion in cash and 77.70 million in debt, giving a net cash position of 4.91 billion.

Cash & Cash Equivalents	4.98B
Total Debt	77.70M
Net Cash	4.91B
Net Cash Per Share	n/a
Equity (Book Value)	5.84B
Book Value Per Share	-135.97
Working Capital	4.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.05 billion and capital expenditures -641.11 million, giving a free cash flow of -2.69 billion.

Operating Cash Flow	-2.05B
Capital Expenditures	-641.11M
Free Cash Flow	-2.69B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-22,968.95%
Pretax Margin	-20,906.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.61%
Shareholder Yield	-60.61%
Earnings Yield	-21.62%
FCF Yield	-44.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.73
Piotroski F-Score	n/a